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Abstract Maintenance of cell size homeostasis is a property that is conserved throughout
eukaryotes. Cell size homeostasis is brought about by the co-ordination of cell division with cell
growth and requires restriction of smaller cells from undergoing mitosis and cell division, whilst
allowing larger cells to do so. Cyclin-CDK is the fundamental driver of mitosis and therefore
ultimately ensures size homeostasis. Here we dissect determinants of CDK activity in vivo to
investigate how cell size information is processed by the cell cycle network in fission yeast. We
develop a high-throughput single-cell assay system of CDK activity in vivo and show that inhibitory
tyrosine phosphorylation of CDK encodes cell size information, with the phosphatase PP2A aiding
to set a size threshold for division. CDK inhibitory phosphorylation works synergistically with PP2A
to prevent mitosis in smaller cells. Finally, we find that diploid cells of equivalent size to haploid
cells exhibit lower CDK activity in response to equal cyclin-CDK enzyme concentrations, suggesting
that CDK activity is reduced by increased DNA levels. Therefore, scaling of cyclin-CDK levels with
cell size, CDK inhibitory phosphorylation, PP2A, and DNA-dependent inhibition of CDK activity, all
inform the cell cycle network of cell size, thus contributing to cell size homeostasis.
Introduction
Cells display homeostatic behaviour in maintaining population cell size by controlling cell size at
mitosis (Fantes et al., 1975; Ginzberg et al., 2015; Wood and Nurse, 2015; Lloyd, 2013). This
homeostasis is driven by larger cells being more likely to divide than smaller cells, resulting in the
correction at cell division of cell size deviances (Fantes et al., 1975; Fantes, 1977; Patterson et al.,
2019). Cyclin-dependent kinase (CDKCdc2) is the master regulator of mitosis and cell division, and
therefore the propensity for smaller cells not to divide must ultimately feed into the regulation of
CDK activity (Coudreuse and Nurse, 2010).
CDK activity is subject to several mechanisms of control: cyclin synthesis and subsequent binding
of cyclin to CDK, which drives CDK into a catalytically competent form Solomon et al., 1990; Wee1
kinase and Cdc25 phosphatase act to inhibit or activate CDK, respectively, through regulatory tyro-
sine phosphorylation (Nurse, 1975; Russell and Nurse, 1986; Gould and Nurse, 1989); and PP2A
phosphatase works to remove phosphates deposited by CDK reducing its net activity
(Kinoshita et al., 1990; Kinoshita et al., 1993; Gharbi-Ayachi et al., 2010; Mochida et al., 2009;
Mochida et al., 2010; Mochida et al., 2016), and also controls the phosphorylation state of Wee1
and Cdc25 to regulate the level of CDK tyrosine phosphorylation (Lucena et al., 2017;
Hutter et al., 2017; Rata et al., 2018; Kamenz et al., 2021). Finally, the CDK control network also
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co-ordinates cell division with cell growth through an unknown mechanism that responds to cell
ploidy, with cell size generally doubling as ploidy doubles (Wood and Nurse, 2015).
It is likely that potential size control pathways will be integrated at the level of CDK activity con-
trol because CDK activity is the driver of mitosis. For example, in the fission yeast Schizosaccharomy-
ces pombe, it has been proposed that size control was mediated by the DYRK kinase Pom1, which
ultimately inhibits mitotic onset by causing the inhibitory tyrosine phosphorylation of CDK by signal-
ling through the Wee1 kinase (Martin and Berthelot-Grosjean, 2009; Moseley et al., 2009). How-
ever, in both the absence of Pom1 itself or the absence of inhibitory tyrosine phosphorylation, cells
are able to maintain cell size homeostasis (Coudreuse and Nurse, 2010; Wood and Nurse, 2013).
Thus, there must exist alternative mechanisms by which fission yeast cells integrate cell size informa-
tion into the CDK control network.
Much of our understanding of cyclin-CDK network regulation has been derived from in vitro stud-
ies, but these have limitations when considering cellular parameters such as cell size (Mochida et al.,
2016; Pomerening et al., 2005; Pomerening et al., 2003; Sha et al., 2003). Here, therefore, we
have studied in vivo regulation of cyclin-CDK activation at mitosis in the fission yeast. Using a novel
CDK activity sensor, we have monitored cell size, CDK activity, and cyclin-CDK complex level simul-
taneously, whilst genetically varying regulators of the cyclin-CDK control system. We propose that
CDK activity regulation through inhibitory tyrosine phosphorylation and PP2A work synergistically to
communicate information about cell size to the CDK control network. Furthermore, we show that
cyclin-CDK complex level scales with cell size, and this aids in the prevention of division in small cells.
Finally, we show that in cells lacking PP2A and inhibitory tyrosine phosphorylation, haploid and dip-
loid cells of equivalent size and similar cyclin-CDK concentration have differing cyclin-CDK activities,
with diploid cells exhibiting a lower activity. This suggests that cyclin-CDK activity is increased in cells
of lower ploidy. These experiments inform our understanding of the regulation of cyclin-CDK and
illuminate how cell size is integrated into this regulatory network.
Results
Given the complexity of the CDK regulatory network, we have used fission yeast cells containing a
reduced CDK control system, with the cell cycle driven by a monomeric cyclin-CDK fusion-protein
(C-CDK) (Coudreuse and Nurse, 2010). This simplifies the CDK control network by eliminating cyclin
binding to CDK as a regulatory component and allows co-expression of both cyclin and CDK from a
single promoter. This C-CDK fusion-protein is expressed under the Cyclin BCdc13 promoter, and
therefore C-CDK expression mimics endogenous Cyclin B expression. Using this system, inhibitory
Wee1-dependent phosphoregulation can also be removed using a non-phosphorylatable C-CDKAF
mutant (Coudreuse and Nurse, 2010; Wood and Nurse, 2013). These C-CDKAF strains are healthy
and viable, but have markedly distinct cell cycle profiles from C-CDKWT expressing strains, as they
spend a significantly longer period in G1 than C-CDKWT cells (Coudreuse and Nurse, 2010). Never-
theless, C-CDKAF cells co-ordinate cell division with cell growth and maintain cell size homeostasis
(Figure 1a; Wood and Nurse, 2013).
To examine the relationship between cell size, C-CDK concentration, and mitosis, we performed
quantitative fluorescence time-lapse microscopy on strains expressing C-CDKWT and C-CDKAF fluo-
rescently tagged with YFP (Figure 1a–e, Figure 1—figure supplement 1, Figure 1—figure supple-
ment 2a). This analysis showed clear oscillations of C-CDKWT and C-CDKAF, with degradation of
C-CDK occurring just before cell division (Figure 1b). C-CDKAF oscillations were more variable, and
5% of the C-CDKAF cells trigger C-CDK degradation in the absence of division (Figure 1—figure
supplement 2), similar to what has been observed in CDK1AF expressing human cells
(Pomerening et al., 2008). In both backgrounds, C-CDK concentration scaled with cell size, with
C-CDKWT exhibiting a higher amount of C-CDK at mitotic entry compared to C-CDKAF (Figure 1c).
On investigating the links between the probability of a given cell to divide, cell size, and C-CDK
level, we found that for C-CDKWT both cell size and C-CDK level reach sharp thresholds at which cell
division rates increase (Figure 1d,e). In the absence of tyrosine phosphorylation, a sharp threshold
for C-CDKAF levels still is present (Figure 1e), but occurs at a lower level than C-CDKWT. C-CDKAF
cells fail to generate a sharp threshold for cell size, but even without a clear size threshold, C-CDKAF
cells still restrict smaller cells from division (Figure 1d).
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Figure 1. Cell size and C-CDK concentration dictate probability of division and CDK activity in C-CDKWT and C-CDKAF cells. (a) Schematic of major
components influencing C-CDK activity at mitosis, and in red, the pathways that do not influence C-CDKAF. The negative relationship between C-CDK
activity and cell growth refers to the block of cell length extension in mitosis. PP2A opposes CDK activity by dephosphorylating CDK substrates, and
also by opposing the activation of CDK at mitosis by opposing the phosphorylation of Wee1 and Cdc25. Reciprocally, CDK causes the downregulation
Figure 1 continued on next page
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C-CDK level is not a direct measure of C-CDK activity because of the multiple regulatory net-
works affecting CDK (Pomerening et al., 2005). To investigate CDK activity, cell size, and C-CDK
level at the same time, we developed an in vivo single-cell assay of CDK activity. We used Cut3, the
Smc4 homolog, as a CDK activity biosensor, because it translocates from the cytoplasm into the
nucleus upon CDK-dependent phosphorylation of a single site in its N-terminus (Figure 1f;
Sutani et al., 1999). Thus, the Cut3 nuclear/cytoplasmic (N/C) ratio can be used to assess CDK activ-
ity, a method that has been applied to other protein kinases (Spencer et al., 2013; Araujo et al.,
2016). As a test of this assay, we blocked cells expressing fluorescently tagged Cut3 in the back-
ground of a bulky ATP-analogue-sensitive C-CDK (Bishop et al., 2000) using 1NM-PP1, and tracked
single cells following their release from G2 arrest into a range of 1NM-PP1 doses (Figure 1g, Fig-
ure 1—figure supplement 3). The response of the maximum nuclear Cut3 concentration to 1NM-
PP1 was similar to the one measured in our previous phosphoproteomics study (Swaffer et al.,
2016), confirming that the sensor reflects in vivo CDK activity (Figure 1h). Subsequently, we exam-
ined CDK activity in unperturbed cells measured by the Cut3 N/C ratio and showed that it both rises
to a higher level in C-CDKWT cells in comparison to C-CDKAF cells and also that progress through
mitosis in C-CDKAF cells is slower and more variable (Figure 1i, Figure 1—figure supplement 4).
We next investigated the links between C-CDK protein levels, CDK activity, and cell size in
C-CDKWT and C-CDKAF cells, which have been enlarged beyond their physiological cell size. During
a G2/M block (Figure 1g), cell size and C-CDK enzyme concentration (as measured by C-CDK-YFP
Figure 1 continued
of PP2A activity in mitosis. (b) Example cell lineage traces from time-lapse microscopy. Cell size in pixels2 is given in orange, and C-CDK-YFP
fluorescence intensity is given in purple. Steep decreases in cell size traces correspond to cell division. (c) Scatter plot of mean C-CDK level vs cell size
from time-lapse microscopy data. C-CDK level is a measure of C-CDK-YFP fluorescence intensity. Colours indicate density of data. Inset boxplot is
mean nuclear C-CDK concentration immediately prior to degradation at anaphase. Boxes represent interquartile range, with whiskers delimiting 5th–
95th percentiles. C-CDKWT n = 28, C-CDKAF n = 44 full cycles. (d) Plot of the probability of division at the next timepoint (P(Div)) vs cell length for
CDKWT and CDKAF. Cells were followed through time-lapse microscopy with measurements taken each frame. P(Div) defined as the proportion of cells
that undergo C-CDK degradation at anaphase by the next timepoint, given as rate per minute. Points represent cells binned by size, with points
plotted at bin centre. C-CDKWT n = 685, C-CDKAF n = 961 timepoints. (e) Plot of P(Div) function vs C-CDK level for CDKWT and CDKAF.
C-CDKWT n = 685, C-CDKAF n = 961 timepoints. C-CDK-YFP intensity measurements taken every frame from time-lapse microscopy, and binned by
C-CDK level. (f) Schematic of Cut3 as a CDK activity reporter. Mitotic CDK-dependent phosphorylation of Cut3 on T19 results in nuclear translocation of
the protein. (g) Experimental outline of block and release time-lapse experiment for panels (h, j–o). Asynchronous cells possessing an analogue
sensitive (as) CDK were blocked in G2 using 1 mM 1NM-PP1 for 5 hr and then released into a range of 1NM-PP1 concentrations. Cells were then
followed and monitored for their Cut3-tdTomato nuclear/cytoplasmic (N/C) ratio (C-CDK activity) and C-CDK-YFP level using fluorescence time-lapse
microscopy (see Materials and methods). Data for (l–o) were acquired 15 min following release from 1NM-PP1. (h) Maximum CDK activity (normalized
against maximum level, obtained by release into DMSO) against 1NM-PP1 concentration. Red points are the median of the data sets for each drug
concentration (N = 324), and green point is median in DMSO. Black line is the Hill equation fit to the median data by a nonl-inear fitting algorithm
(IC50 = 115.4, Hill coefficient =  1.71). Purple dashed line is Hill curve derived from Swaffer et al., 2016 dose–response data (IC50 = 133.4, Hill
coefficient =  1.47). (i) Time-lapse quantification of CDK activity in asynchronous cells. Traces are aligned so that 0 min corresponds to peak Cut3-
tdTomato N/C ratio. Curve smoothing could move Cut3 peak earlier/later than exactly 0 min. Trace colour indicates cell size. Red X indicates
automatically defined mitotic entry point. C-CDKWTn = 23 and C-CDKAFn = 14. (j) Scatter plot of C-CDK-YFP levels against cell size. Experiment
described in (g), with measurements taken before release from 1NM-PP1 block. Black points indicate binned data, bin window size 500 pixels2. n = 324.
Pearson correlation coefficient: 0.55. (k) As in (j), but with C-CDKAF, n = 312. Pearson correlation coefficient: 0.62. (l) Scatter plot of peak Cut3-tdTomato
level vs cell size. Experiment described in (g), with measurements taken 20 min after release from 1NM-PP1 block into DMSO. Black points indicate
binned data, bin window size 500 pixels2. Points are coloured by YFP C-CDK levels at release. n = 83. R2 = 0.5040. Pearson correlation coefficient: 0.50.
(m) As in (l), but with C-CDKAF, n = 81. R2 = 0.2150. Pearson correlation coefficient: 0.22. (n) Scatter plot of peak Cut3-tdTomato level vs C-CDK-YFP
intensity level 20 min after release from 1NM-PP1 block into DMSO. Black points indicate binned data, bin window size 15 AU. Points are coloured by
cell size at release. n = 83. R2 = 0.3668. Pearson correlation coefficient: 0.60. (o) As in (n), but with C-CDKAF, n = 81. R2 = 0.5501. Pearson correlation
coefficient: 0.74.
The online version of this article includes the following figure supplement(s) for figure 1:
Figure supplement 1. Automated image analysis pipeline for wide-field imaging.
Figure supplement 2. Fluorescence time-lapse quantification of C-CDK dynamics in unperturbed cell cycles.
Figure supplement 3. A time-lapse block and release assay to measure the effect of CDK inhibition on CDK activity in single cells.
Figure supplement 4. Cut3-GFP as a marker of CDK activity in WT and AF cell strains.
Figure supplement 5. An imaging flow cytometry assay reveals that size, C-CDK level, and tyrosine phosphorylation dictate the rate and timing of CDK
activation at mitosis.
Figure supplement 6. Size-dependent grading of mitotic entry rates and timing are dose responsively dependent on CDK inhibition.
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fluorescence intensity) scaled with each other in both backgrounds (Figure 1j,k). After the release
from CDK inhibition, C-CDKWT activity correlated well with both cell size and C-CDK protein level
(Figure 1l,n). However, peak C-CDKAF activity correlated better with protein level than with cell size
(Figure 1m,o). The link between cell size and CDK activity was much clearer for C-CDKWT than for
C-CDKAF in these low-throughput time-lapse assays (Figure 1m). Therefore, we repeated this experi-
ment using a high-throughput assay based on imaging flow cytometry (Figure 1—figure supple-
ments 5 and 6) and observed that peak CDK activity in both C-CDKAF and C-CDKWT was clearly size
dependent (Figure 1—figure supplement 5e). Thus, CDK tyrosine phosphorylation helps to inform
the cell division machinery of cell size (Figure 1d,l). However, in the absence of tyrosine phosphory-
lation, C-CDKAF cells are still able to generate a threshold C-CDK level for division and prevent small
cells from division (Figure 1e,o, Figure 1—figure supplement 5e).
A complication of the above assay is that cell size scales with C-CDK level (Patterson et al.,
2019; Coudreuse and Nurse, 2010; Navarro and Nurse, 2012; Figure 1c,j,k). To uncouple cell size
from C-CDK level, and study if small cells are prevented from entering mitosis due to low C-CDK
level or for some other reason, we developed a more flexible single-cell CDK assay system. This
assay was also based on Cut3 translocation into the nucleus (Figure 2a) but used a brighter synthetic
C-CDK activity sensor, synCut3-mCherry to allow its co-detection with C-CDK in a high-throughput
assay (Figure 2—figure supplement 1). This sensor was expressed in a strain where the endogenous
CDK network can be switched off using a temperature-sensitive CDK1 allele, cdc2TS. A tetracycline-
inducible C-CDK tagged with superfolder GFP (sfGFP) was constructed and made non-degradable
(Yamano et al., 1998) as well as sensitive to inhibition by 1NM-PP1. Induction of C-CDK at the
cdc2TS restrictive temperature allows the study of the activity of the inducible C-CDK without either
wild-type CDK activity or C-CDK-sfGFP proteolysis during mitosis. Using this assay, we acquired hun-
dreds of thousands of images of single cells, which allowed us to study the in vivo biochemistry of
CDK activity in response to a wide range of C-CDK concentrations in physiologically sized cells.
C-CDK level was uncoupled from cell size as induction of C-CDK was not dependent on cell size
(Figure 2b,c). Results from this assay demonstrated that in vivo CDK activity was dependent on
C-CDK level and was reduced when CDK activity was inhibited using 1NM-PP1 (Figure 2d, Fig-
ure 2—figure supplement 2).
Combining this system with genetic backgrounds in which major C-CDK regulation was altered,
we analysed how mechanisms of CDK regulation affected C-CDK activity in relation to cell size. We
performed the assay in backgrounds lacking the major PP2A catalytic subunit (PP2Appa2D)
(Kinoshita et al., 1990; Kinoshita et al., 1993), inhibitory CDK tyrosine phosphorylation, or both
(Figure 2e). Following endogenous CDK1 inactivation after temperature shift, both PP2A+ and
PP2AD cells arrest in an almost uniform G2 state, ensuring that downstream analysis is not con-
founded by cells arresting in different phases of the cell cycle (Figure 2f). C-CDK levels increased
similarly upon induction in all mutant backgrounds (Figure 2g). Population mean C-CDK activity was
comparable between all conditions (Figure 2h); however, C-CDK activity displayed differences at
the single-cell level when activity was measured in cells of different sizes. In all genetic backgrounds
at the same level of C-CDK enzyme, maximum C-CDK activity increases with cell size (Figure 2i).
This is particularly noticeable when directly comparing the maximum C-CDK activity of cells with a
C-CDK level of ~750 AU in the 8 mm bin to the 14 mm bin in all backgrounds (Figure 2i, dashed
lines). The single-cell dose–response of CDK activity on C-CDKWT concentration background is
clearly bistable, with cells existing in either an ‘on’ or an ‘off’ state. The mean CDK activity is relevant
directly for strains expressing C-CDKAF, as these cells exhibit little bistability in CDK activation. In
the C-CDKWT expressing cells, there are two population distributions demonstrating bistability. We
averaged the two population means as the gradient of this line shows the degree of bifurcation
between the lower and the upper CDK activity populations. The C-CDK concentration required to
switch cells ‘on’ decreases with increasing cell size, and the sharpness of the transition increases with
size (Figure 2i,k). This bistable behaviour is heavily dependent on CDK tyrosine phosphorylation
(Figure 2i,k,l). Removal of PP2A allows the attainment of the ‘on’ state at lower cell sizes (Figure 2i),
effectively shifting the C-CDK dose–response curve towards lower sizes without altering the shape
of the response (Figure 2k). In addition, PP2A also adds switch like behaviour to the C-CDK activity
dose-response, as bistable behaviour with C-CDKAF is not present with C-CDKAF PP2AD (Figure 2i
dashed box, inset and Figure 2l).
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Figure 2. Cell size is able to modulate CDK activity independently of canonical CDK regulation. (a) Experimental outline for figure for (b–d). Cells were
held at 36˚C for 1 hr to ablate the function of the temperature-sensitive (TS) cdc2 allele. C-CDK-sfGFP expression was induced by addition of
tetracycline, and ectopic C-CDK concentration and CDK activity were measured by sequential sampling during induction. Induced C-CDK-sfGFP lacks
its degron box sequence, and therefore is not degraded at anaphase. Sequential sampling during C-CDK-sfGFP induction begins at the point of
Figure 2 continued on next page
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When looking across all size bins, maximum C-CDK activity increases with cell size in all genetic
backgrounds, but plateaus at about 12–13 mm in the absence of tyrosine phosphorylation
(Figure 2j). However, it is clear that cell size is able to regulate C-CDK activity even in the absence
of both tyrosine phosphorylation and PP2A (Figure 2i,j). These results are consistent with our previ-
ous observations (Figure 1), that although tyrosine phosphorylation has a role in informing the cell
cycle machinery of cell size, small cells are still restricted from mitosis when tyrosine phosphorylation
is absent.
Inhibitory tyrosine phosphorylation directly results in a reduction of intrinsic CDK activity
(Berry and Gould, 1996), whilst PP2A has a dual mechanism of CDK activity modulation: PP2A is
able to regulate inhibitory tyrosine phosphorylation by controlling the phosphorylation state of
Wee1 and Cdc25 (Lucena et al., 2017), and in addition can directly oppose the phosphorylation of
CDK substrates (Godfrey et al., 2017). We therefore sought to calculate the contributions of tyro-
sine phosphorylation and PP2A in restricting CDK activity, both in contexts with and without tyrosine
phosphorylation. This was carried out to examine if their combined contribution was greater than
the sum of their parts. To calculate the individual contributions of tyrosine phosphorylation and
PP2A in restricting C-CDK activity, first we measured the threshold C-CDK level required for 50% of
cells to reach a C-CDK activity determined as being >5 in arbitrary units (see Figure 3 legend) in dif-
ferent strain backgrounds within different size bins (Figure 3a). This value was chosen as an approxi-
mate value of the C-CDK concentration required in vivo to trigger mitotic entry in wild-type cells
(Figure 1i). When this C-CDK threshold level was plotted across all size bins (Figure 3b), the thresh-
old was seen to be size dependent in all strain backgrounds, with wild-type cells exhibiting the stron-
gest capacity to raise the C-CDK level threshold for mitosis in smaller cells. By subtracting the curves
of cell length vs mitotic C-CDK level (Figure 3c) for various backgrounds, we were able to estimate
the contributions of tyrosine phosphorylation and PP2A in a given background. For example,
C-CDKWT PP2AD–C-CDKAF PP2AD estimates the ability of tyrosine phosphorylation alone to restrict
mitotic entry in a background lacking PP2A. Inhibitory tyrosine phosphorylation is able to restrict
cells with 600 units of C-CDK from entering mitosis at 8 mm cell length, but only 200 units of C-CDK
at 10 mm (Figure 3c, yellow). If the different components of the CDK control network act separately,
adding individual threshold contributions together would generate a threshold curve similar to the
wild-type curve. However, when the contributions of tyrosine phosphorylation and PP2A were added
Figure 2 continued
tetracycline addition, with roughly one sample taken every 3 min after the start of C-CDK production. Sampling is conducted using an imaging flow
cytometer (IMS). (b) Expression of C-CDKWT from point of tetracycline addition. Different coloured lines represent different size bins. Black dots
represent mean C-CDK-sfGFP level over all size bins for given timepoint. After lag period of ~1000 s after tetracycline addition, samples are taken
roughly every 3 min. n = 759,633. (c) Scatter plot of cell length vs C-CDK-sfGFP levels. Coloured by density of data points. Data collected throughout
induction. n = 759,633. (d) Mean CDK activity dose–response against C-CDK-sfGFP in the presence of annotated levels 1NM-PP1. Circles represent
average CDK activities across all cells from a single sample taken after induction. 0 nM n = 166,081; 125 nM n = 60,759; 250 nM n = 165,128; 500 nM
n = 135,670; and 1000 nM n = 231,995. (e) Experimental outline for (f–k). Cells were held at 36˚C for 1 hr to ablate cdc2TS function. After 1 hr, C-CDKWT
or C-CDKAF fused to sfGFP was induced with tetracycline in cells with either the major PP2A catalytic subunit (encoded by the ppa2 gene) deleted or
present. Induced C-CDK-sfGFP lacks its degron box sequence, and therefore is not degraded at anaphase. Sequential sampling during C-CDK-sfGFP
induction begins at the point of tetracycline addition, with timepoints taken roughly every 3 min after 1000s lag period in C-CDK-sfGFP induction. (f)
Flow cytometric DNA content analysis for wild-type cells, cdc2-M26 cells, and cdc2-M26 PP2AD cells. The major PP2A, ppa2, was deleted in PP2AD
cells. Cells were fixed for sampling after the block lengths specified in (e), before the addition of tetracycline. (g) Induction of C-CDK after tetracycline
addition. Points represent mean concentration of C-CDK-sfGFP across all size bins at indicated timepoints. CDKWTn = 166,081. C-CDKWT PP2AD
n = 175,247. C-CDKAFn = 177,292. C-CDKAF PP2AD n = 174,847. (h) C-CDK activity against C-CDK-sfGFP level in given genetic backgrounds defined in
(g). Points represent mean C-CDK activity of all cells. Data is pooled from experiment in (e), from all timepoints following tetracycline induction. Key is
the same as (g). (i) Violin plots of single-cell C-CDK-sfGFP level against CDK activity in annotated size bins and strain backgrounds. Solid line through
violin plot indicates the mean CDK activity within the C-CDK level bin. (j) Maximum mean CDK activity vs cell length in annotated strain backgrounds.
Max mean CDK activity is the maximum mean CDK activity within a C-CDK fluorescence level bin for a given cell size. The mean CDK activity level
across all fluorescence bins is shown by the solid line in the violin plots in (i). (k) Maximum gradient of the mean lines in (i) plotted against cell length.
Maximum gradient of change is derived from a spline fit to the mean CDK activity vs C-CDK-sfGFP level trace. (l) Linear regression lines were fit to data
in (k), and residuals were plotted (actual value – predicted value). Non-linear residuals indicate bistability in CDK activation.
The online version of this article includes the following figure supplement(s) for figure 2:
Figure supplement 1. A new synthetic CDK sensor for S. pombe.
Figure supplement 2. A single-cell in vivo biochemistry approach permits decoupling of cell size from C-CDK concentration.
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to the C-CDKAF PP2AD curve, they did not re-capitulate the wild-type curve (Figure 3d). Thus, this
analysis suggests that there is synergy between the tyrosine phosphorylation network and PP2A
activity and that this synergy is important for establishing the C-CDK level threshold for division.
We have shown that small cells are normally prevented from division by their low C-CDK protein
level (Figure 1), along with PP2A and tyrosine phosphorylation working synergistically to increase
the level of C-CDK needed to trigger division in smaller cells (Figure 3). Strikingly however, in the
absence of these major regulators, small cells are still able to restrict division by lowering CDK activ-
ity as a result of some other factor related to cell size (Figure 2h,i,j). This unknown factor is able to
lower CDK activity in small cells despite high C-CDK levels, thus restricting them from division
(Figure 2i).
Given the positive relationship between maximum C-CDK activity and increasing cell size in the
C-CDKAF PP2AD mutant (Figure 2i), we hypothesized that cells dilute a CDK inhibitor as they grow
(Fantes et al., 1975), perhaps through a titration-based mechanism. Cell size is linked to ploidy
Figure 3. CDK tyrosine phosphorylation and PP2A act synergistically to restrict division in small cells. (a) Scatter plots of C-CDK level against CDK
activity. Either C-CDKWT or C-CDKAF fused to sfGFP was induced in backgrounds with PP2A either lacking or present. PP2AD refers to a deletion of the
ppa2 gene. Red line indicates the C-CDK-sfGFP level at which 50% of cells have a CDK activity greater than 5. Black dashed line marks CDK activity of
5. Data taken from Figure 2i. (b) C-CDK-sfGFP level at which 50% of cells have C-CDK activity of >5. Data is taken from (a) across all size bins. Y-axis
represents the C-CDK-sfGFP threshold at which 50% of cells will have a C-CDK activity of 5. Dashed lines indicate values where this C-CDK-sfGFP
threshold level is undefined due to the threshold being unattainable in experimental conditions. (c) Piecewise dissection of the amount of C-CDK-sfGFP
a particular component of the cell cycle network is able to prevent from switching to an ‘on’ state (C-CDK activity level of 5) in different size bins. Bar
chart shown is of subtractions of curves described in key (inset). For example, C-CDKWT–C-CDKAF gives the C-CDK threshold tyrosine phosphorylation
alone (in a background with PP2A present) is able to generate to restrict C-CDK activation. Values that are undefined due to undefined original
threshold values from (a) are taken to be 1000 units and are marked above the axis (pink). (d) Cell length against C-CDK level threshold of annotated
curves. Here, a synthetic threshold curve is built (pink), by adding the individual component regulatory contributions of CDK tyrosine phosphorylation
(c, yellow) and PP2A (c, orange) to the base curve of C-CDKAF PP2AD (green) to try and re-capitulate the WT behaviour (blue). Dashed line indicates
undefined threshold values.
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through an unknown mechanism, and so we tested whether DNA concentration could influence CDK
activity, and therefore be a candidate for the unknown factor able to lower C-CDK activity in small
cells. We induced C-CDKAF in haploid and diploid variants of the C-CDKAF PP2AD strain, thereby
eliminating all major CDK regulation at mitosis (Figure 4a). Both haploid and diplod cells were pres-
ent almost uniformly in G2 after endogenous CDK1 inactivation, as cells with 2C and 4C DNA con-
tent respectively (Figure 4b), and expressed C-CDKAF-sfGFP in a largely size-independent manner
(Figure 4c). Strikingly, diploid cells exhibited lower C-CDK activity in response to the same C-CDK
enzyme concentration as haploids (Figure 4d). The EC50 of the diploid dose–response curve was
almost double that of the haploid (Figure 4e). Looking at single-cell, volume-resolved data, the inhi-
bition of C-CDK activity is most marked in smaller diploid cells, with larger diploid cells having
almost indistinguishable dose–response curves from their haploid equivalents (Figure 4f). The effect
of cell size on CDK activation is much less marked in larger than normal haploids (Figure 4g). The
diploids, which feature cells of physiological diploid size, still experience DNA concentration-depen-
dent inhibition of their CDK activity. The effect of equal C-CDK levels resulting in lower C-CDK activ-
ity in small diploids when compared to equivalent sized haploids is readily seen from the raw images
(Figure 4h). Therefore, cells of different ploidies, but otherwise equivalent volume, experience vari-
able CDK activity in response to equal C-CDK level. This suggests that even in the absence of all
major CDK regulation, DNA concentration is able to lower CDK activity and prevents division in
small cells. At higher volumes, this inhibition of CDK activity disappears, and so the regulation may
operate through titrating out an inhibitor.
Discussion
The cyclin-CDK complex, and its role in controlling mitotic onset, has been studied in many model
eukaryotes from yeast (Nurse et al., 1976), through marine invertebrates (Evans et al., 1983), to
mammalian cells (Santos et al., 2012). A number of regulatory components have been shown to be
conserved across these model systems, including the CDK-activating cyclin B, inhibitory CDK tyro-
sine phosphorylation, and the CDK-counteracting PP2A phosphatase which both opposes CDK sub-
strate phosphorylation and regulates CDK inhibitory phosphorylation through the Wee1/Cdc25
control loop. Despite extensive study, these studies have yet to reveal a fully satisfactory mechanism
for cell size homeostasis at the onset of mitosis. To improve our understanding of this control sys-
tem, we have focused on how CDK activity itself is directly regulated in the context of cell size. Our
approach has demonstrated that three mechanisms inform the cell cycle control network of cell size
through CDK activity control: C-CDK enzyme concentration scaling with cell size, synergistic PP2A
and tyrosine-phosphorylation-dependent C-CDK threshold scaling, and DNA concentration-depen-
dent inhibition of CDK activity. Our results demonstrate that C-CDK activity vs C-CDK level dose–
response curves previously demonstrated in vitro operate in vivo, but in addition, we show that they
are dependent on cell size in vivo (Pomerening et al., 2003). We also demonstrate a link between
ploidy and CDK activity, with higher ploidy causing a reduction in CDK activity. We propose that
CDK activity can be inhibited by a DNA-related mechanism in keeping with early work showing that
increasing DNA content delays mitosis, with the removal of DNA by irradiation causing acceleration
of the following mitosis (Devi et al., 1968; Sachsenmaier et al., 1970; Wilson, 1925). Our experi-
ments show that DNA inhibits CDK activity more in smaller cells, potentially reducing CDK activity
by a titration mechanism. This may be related to the mechanism by which cell size is linked to ploidy
across cell types (Wilson, 1925; Amodeo and Skotheim, 2016; Prescott, 1956; Tzur et al., 2009).
Finally, we show that tyrosine phosphorylation, PP2A activity, and DNA-dependent inhibition of CDK
activity act together to restrict small cells from division, forming a mechanism to generate the robust
cell size threshold behaviour observed in normal cells.
Our observations suggest that cell size control over the onset of mitosis involves several molecu-
lar mechanisms. If it is assumed that the accumulation of the C-CDK cyclin chimera driven by the
cyclin promoter mimics the accumulation of cyclin, then one mechanism is the accumulation of cyclin
through the cell cycle, which scales with the increase in cell size. A second is a synergistic interaction
between the inhibitory CDK tyrosine phosphorylation pathway and the PP2A phosphatase, which
acts on both the tyrosine phosphorylation pathway and dephosphorylation of CDK substrates. The
third is a DNA-concentration-dependent inhibition of CDK activity. Given the conservation of all
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Figure 4. Cellular DNA content inhibits CDK activity independently of tyrosine phosphorylation or PP2A activity. (a) Experimental outline for panels (b)-
(h). PP2A D/D diploids and PP2AD haploids were arrested using cdc2TS. PP2AD refers to a deletion of the ppa2 gene. Diploids were held at 36˚C for 1
hr, whilst haploids were held for 3 hr to generate blocked cell populations with similar cell volumes despite ploidy differences. C-CDKAF expression was
induced by addition of tetracycline, and C-CDKAF-sfGFP concentration and CDK activity were measured by sequential sampling from time of induction
in an imaging flow cytometer. (b) Flow cytometric DNA content analysis for wild-type cells, haploid cdc2-M26 PP2AD cells and diploid cdc2-M26/cdc2-
M26 PP2AD/PP2AD cells. PP2AD refers to a deletion of the ppa2 gene. Cells were fixed for sampling after the block lengths specified in (a), before the
addition of tetracycline. (c) Expression of C-CDKAF fused to sfGFP from point of tetracycline addition in haploid and diploid strains. Different coloured
lines represent different size bins. Haploid n = 125,021, diploid n = 139,557. (d) Mean CDK activity against C-CDKAF-sfGFP level in haploids and
diploids. Solid line is a sigmoid fit to data. (e) EC50 from sigmoid curves in (d). Haploid EC50: 372 AU. Diploid EC50: 663 AU. Haploid EC50 is 56% of
diploid EC50. (f) Violin plots of single-cell C-CDKAF-sfGFP level against CDK activity in annotated volume bins and ploidy status. Solid line through
Figure 4 continued on next page
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these molecular regulators, these mechanisms can be expected to have direct relevance in other
eukaryotic cells.
Materials and methods
S. pombe genetics and cell culture
S. pombe media and standard methods are as previously described (Moreno et al., 1991). After
nitrogen and glucose addition, EMM was filter sterilised. This process allows for the generation of
clear un-caramelised media. Nutritional supplements for auxotrophic yeast strains were added at a
concentration of 0.15 mg/ml. Temperature-sensitive mutant strains were grown at temperatures as
specified in the text. The temperature-sensitive allele of Cdc2 (CDKTS) used was Cdc2-M26. To mod-
ulate inducible promoters, anhydrotetracycline hydrochloride (Sigma) in DMSO at specified concen-
trations was added to 0.03125 mg/ml final concentration unless otherwise specified. To alter Cdc2
(as) activity, 1NM-PP1 diluted in DMSO was used at concentrations specified in the text. To stain for
septa, calcofluor (Fluorescent Brightener 28 [Sigma-Aldrich]) was made up in water at 1 g/l and
stored as 500 stock. SynCut3 was constructed by Gibson assembly of a codon-optimised fragment
consisting of the first 528 amino acids of Cut3, a linker region, and a fluorescent protein (mCherry or
mNeongreen). YFP was tagged onto C-CDK at the C-terminus of the protein. Where the sfGFP
labelled C-CDK was used, the sfGFP was present internally within the Cdc13 component
(Basu et al., 2020; Kamenz et al., 2015). Cut3-mCherry was generated by C-terminal tagging
(Bähler et al., 1998), and Cut3-GFP was developed previously (Sutani et al., 1999). Details of the
TetR promoter and linearised variants can be found in a previous publication (Patterson et al.,
2019). All S. pombe strains used in this study are listed in Table 1.
Microscopic imaging
All imaging was performed using a Deltavision Elite (Applied Precision) microscope – an Olympus
IX71 wide-field inverted fluorescence microscope with a PLAN APO 60 oil, 1.42 NA objective and
a Photometrics CoolSNAP HQ2 camera. To maintain specified temperatures during imaging, an
IMSOL imcubator Environment control system and an objective heater was used. SoftWoRx was
used to set up experiments. Five z-stacks were acquired, with 1 mm spacing. Image analysis was per-
formed using custom Matlab scripts that executed the steps outlined in Figure 1—figure supple-
ment 1.
The ONIX Microfluidics platform allows for long-term time-lapse imaging of live cells. Plate details
can be found at http://www.cellasic.com/ONIX_yeast.html. Fifty microlitres of cell culture at density
1.26  106/ml was loaded into the plate and imaged in the 3.5 mm chamber. Cells were loaded at 8
psi for 5 s. Media was perfused at a flow rate of 3 psi. The imaging chamber was washed with media
for 1 min at 5 psi before cells were loaded.
Mattek glass bottom dishes were used for some time-lapse imaging applications with drugs that
were incompatible with Cellasics plates, primarily for the purpose of release from a 1NM-PP1/Cdc2
(as) cell cycle block. Dishes were pre-treated with soybean lectin to permit cell adherence (Sigma-
Aldrich). Before the addition of cells, Mattek dishes were pre-warmed on a heatblock at appropriate
temperature. Cells were grown and blocked in liquid culture before 2 ml were pelleted (5000 rpm/
30 s). Cell pellets were then pooled and resuspended in 1 ml of release media (at which time a stop
watch was started) in a new microcentrifuge tube before pelleting (5000 rpm/30 s) and resuspended
in 5 ml of media. This concentrated cell suspension was then applied to the centre of the Mattek dish
and allowed to settle for ~5 s. The dish was then washed with 1 ml of release media 3. The dish
Figure 4 continued
violin plot indicates the mean CDK activity within the C-CDK-sfGFP level bin. Volume bins span a physiological range of diploid cell sizes. Volume bin
17 corresponds to a haploid cell length of 12.1 mm and a diploid cell length of 9.53 mm. Volume bin 36 corresponds to a haploid length of 18.7 mm and
a diploid length of 14.4 mm. (g) Mean intra volume-bin dose–response of C-CDK-sfGFP level vs CDK activity in annotated ploidy level. Lines are sigmoid
curves fit to raw data. Cell volume bin indicated by line colour. (h) Example raw images from experiment. Brightfield (BF) channel displaying cell
morphology, C-CDK-sfGFP channel and synCut3-mCherry CDK activity indicator are shown. C-CDK level is the same across all images. Scale bars = 3
mm.
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was then filled with 3 ml of release media before rapid imaging. In general, the wash process
required 1.5 min, and imaging setup requires 5 min for ~8 fields of view. The levels of Cut3 and
C-CDK referred to in the paper reference the concentration of both these proteins. This was mea-
sured by finding the mean intensity of the brightest group of 9 pixels within the cell, to give a mea-
surement of the concentration.
Table 1. S. pombe strains.
Strain
ID Strain genotype Source
JP223 h? leu1::cdc13P:cdc13-cdc2.as†-YFP:cdc13T::ura4 cdc13D::natMX6 cdc2::scLeu2 This
work
JP224 h? leu1::cdc13P:cdc13-cdc2AF.as†-YFP:cdc13T::ura4 cdc13D::natMX6 cdc2::scLeu2 This
work
JP670 h? leu1::cdc13P:cdc13-cdc2.as†-YFP:cdc13T::ura4 cdc13D::natMX6 cdc2::scLeu2 ura4::Ppcna1-CFP-pcna cut3-mCherry::hphMX6 This
work
JP671 h? leu1::cdc13P:cdc13-cdc2AF.as†-YFP:cdc13T::ura4 cdc13D::natMX6 cdc2::scLeu2 ura4::Ppcna1-CFP-pcna cut3-mCherry::hphMX6 This
work
JP310 h? leu1::cdc13P:cdc13-cdc2.as†:cdc13T::ura4 cdc13D::natMX6 cdc2::scLeu2 cut3-tdTomato::hphMX6 This
work
JP311 h? leu1::cdc13P:cdc13-cdc2AF.as†:cdc13T::ura4 cdc13D::natMX6 cdc2::scLeu2 cut3-tdTomato::hphMX6 This
work
JP295 h? leu1::cdc13P:cdc13-cdc2AF.as†:cdc13T::ura4 cdc13D::natMX6 cdc2::scLeu2 cut3-GFP::ura4 This
work
JP296 h? leu1::cdc13P:cdc13-cdc2.as†:cdc13T::ura4 cdc13D::natMX6 cdc2::scLeu2 cut3-GFP::ura4 This
work
JP501 h? cdc2.as‡::blastMX6 synCut3-mNeongreen:: leu1+ This
work
JP507 h? cdc2.as‡::blastMX6 synCut3-T19V-mNeongreen:: leu1+ This
work
JP601 h? synCut3-mCherry:: leu1 + cut3-GFP::ura4 This
work
JP602 h? cdc2.as‡::blastMX6 synCut3-mCherry::leu1 + cut3-GFP::ura4 This
work
JP591 h? cdc2-M26 synCut3-mCherry::leu1 + leu1::enoTetP:cdc13-sfGFP-cdc2.as†:adh1T::hphMX6 TetR13 This
work
JP593 h? cdc2-M26 synCut3-mCherry::leu1 + leu1::enoTetP:cdc13-sfGFP-cdc2AF.as†:adh1T::hphMX6 TetR1* This
work
JP603 h? cdc2-M26 synCut3-mCherry::leu1 + leu1::enoTetP:DBDcdc13-sfGFP-cdc2.as†:adh1T::hphMX6 TetR1* This
work
JP605 h? cdc2-M26 synCut3-mCherry::leu1+ (JPp178) leu1::enoTetP:DBDcdc13-sfGFP-cdc2AF.as†:adh1T::hphMX6 TetR1* This
work
JP679 h? cdc2-M26::blastMX6 synCut3-mCherry::leu1 + leu1::enoTetP:DBDcdc13-sfGFP-cdc2.as†:adh1T::hphMX6 TetR1* ppa2D::kanMX6 This
work
JP680 h? cdc2-M26::blastMX6 synCut3-mCherry::leu1 + leu1::enoTetP:DBDcdc13-sfGFP-cdc2AF.as†:adh1T::hphMX6 TetR1* ppa2D::kanMX6 This
work
SB175 h? cdc2-M26 synCut3-mCherry::leu1 + leu1::enoTetP: DBDcdc13-sfGFP-cdc2AF.as†:adh1T::hphMX6 TetR1* ppa2D::kanMX6 This
work
SB176 h?/h? cdc2-M26/cdc2-M26_ synCut3-mCherry::leu1+/synCut3-mCherry::leu1+




*TetR1 – CMVP:TetOx1:TetR-tup11D70 (described originally by Patterson et al., 2019).
†Cdc2(F84G).
‡Cdc2(F84G, K79E).
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Imaging flow cytometry
Imaging flow cytometry was performed with an Imagestream Mark X two-camera system (Amnis),
using the 60 objective. Cells were concentrated by centrifugation (5000 rpm/30 s) and resus-
pended in ~25 ml of media before sonication in a sonicating water bath. In focus, single cells were
then gated by applying the following gating methods in sequence:
1. Gradient RMS > 65 (a measure of cell focus).
2. Area/aspect ratios consistent with single cells.
To avoid any autofocus based drift within an experiment, cell were imaged at fixed, empirically
determined focal points, designed to maximise the number of cells with gradient RMS > 65. Data
was analysed using custom Matlab scripts. The steps these scripts executed were similar to the
image processing pipeline for wide-field imaging (Figure 1—figure supplement 1) albeit slightly
simplified given the presence of only a single cell per image. The Imagestream acquires two bright-
field images of a cell, allowing definition of a cell region using the standard deviation of pixels
between the two. This is analogous to the approach used for time-lapse cell region segmentation
(Figure 1—figure supplement 1).
A line was then drawn through the middle of the cell, by finding the middle pixel on the horizon-
tal axis of the cell. The line was widened by one pixel either side, and the mean fluorescence inten-
sity within that line extracted. The standard peak finding algorithm within Matlab was then used to
identify nuclear Cut3 fluorescence (either a dip in the case of a low CDK activity cell or a peak in the
case of a high CDK activity cell). Background or ‘cytoplasmic’ fluorescence was defined by the inten-
sity of the flat regions of the curve either side of the peak. The levels of Cut3 and C-CDK referred to
in the paper reference the concentration of both these proteins. This was measured by finding the
mean intensity of the brightest group of 9 pixels within the cell, to give a robust measurement of the
concentration.
To perform time-lapse imaging flow cytometry (IMS), water baths at specified temperatures for
the experiment were set up with cultures next to the IMS. Time was measured from the point of
drug addition to liquid culture or as described during a wash protocol for drug release. Samples
were collected as above from the waterbath, and sample timepoints defined as the time at which
acquisition on the IMS began (as opposed to time when sample was collected – although this was
consistently ~3 min apart). Samples were imaged for ~1 min unless otherwise stated.
Data analysis and plotting
Boxplots
The top of box is the 25th percentile of the data, and the bottom is the 75th percentile. The line in
the middle of the box is the median. Whisker lengths are either the distance to the furthest point
outside of the box, or 1.5 the interquartile range, whichever is lower. If data exists that is greater
than 1.5, the interquartile range from the top or bottom of the box, this is shown as a red ‘+’.
Statistical testing
Statistical testing was performed where appropriate using a two-tailed two-sample t-test. p-values
below 0.05 were considered significant. Replicates are shown where appropriate by N numbers.
Cell size measurement
Cell size was measured by three different metrics. In time-lapse microscopy assays, cell size was
determined as the area of the 2D surface segmented by our segmentation algorithm. In the high-
throughput imagestream assays, cell size was measured as length of the cell. The difference in metric
choice between these two systems was due to improved ability of measuring cell length in the high-
throughput assay, where it was less affected by focal-dependent changes in cell volume. In the hap-
loid vs diploid experiments, a measure of cell volume was used, where cells were assumed to behave
as cylinders, and volume was calculated from the measured radius and length. This was done as dip-
loids are wider than haploids, and thus a simple length metric cannot be employed for size binning.
Patterson et al. eLife 2021;10:e64592. DOI: https://doi.org/10.7554/eLife.64592 13 of 17
Research article Cell Biology Computational and Systems Biology
Acknowledgements
We thank Jessica Greenwood and Clovis Basier for their extensive efforts in editing the manuscript.
This work was supported by the Francis Crick Institute that receives its core funding from Cancer
Research UK (FC01121), the UK Medical Research Council (FC01121), and the Wellcome Trust
(FC01121). In addition, this work was supported by the Wellcome Trust Grant to PN (grant number
214183 and 093917), The Lord Leonard and Lady Estelle Wolfson Foundation, and Woosnam Foun-
dation. JOP and PR acknowledge the support of the Biotechnology and Biological Sciences Research
Council under grant BB/P026818/1. PR also acknowledges the support of the Biotechnology and
Biological Sciences Research Council/National Science Foundation under grant BB/N005163/1 and
NSF DBI 1458626. JOP acknowledges support from the Boehringer Ingelheim Fonds PhD fellowship.
For the purpose of Open Access, the author has applied a CC BY public copyright licence to any
Author Accepted Manuscript version arising from this submission.
Additional information
Funding
Funder Grant reference number Author
Boehringer Ingelheim Fonds James Oliver Patterson
Cancer Research UK FC01121 James Oliver Patterson
Souradeep Basu
Paul Nurse
Medical Research Council FC01121 James Oliver Patterson
Souradeep Basu
Paul Nurse
Wellcome Trust FC01121 James Oliver Patterson
Paul Rees
Paul Nurse
Wellcome Trust 214183 James Oliver Patterson
Souradeep Basu
Paul Nurse










National Science Foundation 1458626 Paul Rees
Wellcome Trust 093917 James Oliver Patterson
Paul Rees
Paul Nurse
The funders had no role in study design, data collection and interpretation, or the
decision to submit the work for publication.
Author contributions
James Oliver Patterson, Conceptualization, Software, Formal analysis, Validation, Investigation, Visu-
alization, Methodology, Writing - original draft; Souradeep Basu, Investigation, Writing - original
draft, Writing - review and editing; Paul Rees, Data curation, Formal analysis, Visualization, Method-
ology, Writing - review and editing; Paul Nurse, Conceptualization, Supervision, Funding acquisition,
Project administration, Writing - review and editing
Author ORCIDs
James Oliver Patterson https://orcid.org/0000-0003-1993-4500
Souradeep Basu https://orcid.org/0000-0003-4448-8688
Patterson et al. eLife 2021;10:e64592. DOI: https://doi.org/10.7554/eLife.64592 14 of 17
Research article Cell Biology Computational and Systems Biology





. Transparent reporting form
Data availability
Analysed data has been uploaded to Figshare with the handle 10779/crick.14633037.
The following dataset was generated:




JO, Rees P, Nurse P
2021 Source data for "CDK control
pathways integrate cell size and







Amodeo AA, Skotheim JM. 2016. Cell-Size Control. Cold Spring Harbor Perspectives in Biology 8:a019083.
DOI: https://doi.org/10.1101/cshperspect.a019083, PMID: 26254313
Araujo AR, Gelens L, Sheriff RS, Santos SD. 2016. Positive Feedback Keeps Duration of Mitosis Temporally
Insulated from Upstream Cell-Cycle Events. Molecular Cell 64:362–375. DOI: https://doi.org/10.1016/j.molcel.
2016.09.018, PMID: 27768873
Bähler J, Wu JQ, Longtine MS, Shah NG, McKenzie A, Steever AB, Wach A, Philippsen P, Pringle JR. 1998.
Heterologous modules for efficient and versatile PCR-based gene targeting in Schizosaccharomyces pombe.
Yeast 14:943–951. DOI: https://doi.org/10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y,
PMID: 9717240
Basu S, Roberts EL, Jones AW, Swaffer MP, Snijders AP, Nurse P. 2020. The hydrophobic patch directs cyclin B
to centrosomes to promote global CDK phosphorylation at mitosis. Current Biology 30:883–892. DOI: https://
doi.org/10.1016/j.cub.2019.12.053, PMID: 32084401
Berry LD, Gould KL. 1996. Regulation of Cdc2 activity by phosphorylation at T14/Y15. Progress in Cell Cycle
Research 2:99–105. DOI: https://doi.org/10.1007/978-1-4615-5873-6_10, PMID: 9552387
Bishop AC, Ubersax JA, Petsch DT, Matheos DP, Gray NS, Blethrow J, Shimizu E, Tsien JZ, Schultz PG, Rose MD,
Wood JL, Morgan DO, Shokat KM. 2000. A chemical switch for inhibitor-sensitive alleles of any protein kinase.
Nature 407:395–401. DOI: https://doi.org/10.1038/35030148, PMID: 11014197
Coudreuse D, Nurse P. 2010. Driving the cell cycle with a minimal CDK control network. Nature 468:1074–1079.
DOI: https://doi.org/10.1038/nature09543, PMID: 21179163
Devi VR, Guttes E, Guttes S. 1968. Effects of ultraviolet light on mitosis in Physarum polycephalum. Experimental
Cell Research 50:589–598. DOI: https://doi.org/10.1016/0014-4827(68)90421-7, PMID: 5690891
Evans T, Rosenthal ET, Youngblom J, Distel D, Hunt T. 1983. Cyclin: a protein specified by maternal mRNA in sea
urchin eggs that is destroyed at each cleavage division. Cell 33:389–396. DOI: https://doi.org/10.1016/0092-
8674(83)90420-8, PMID: 6134587
Fantes PA, Grant WD, Pritchard RH, Sudbery PE, Wheals AE. 1975. The regulation of cell size and the control of
mitosis. Journal of Theoretical Biology 50:213–244. DOI: https://doi.org/10.1016/0022-5193(75)90034-x,
PMID: 1127959
Fantes PA. 1977. Control of cell size and cycle time in Schizosaccharomyces pombe. Journal of Cell Science 24:
51–67. PMID: 893551
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